Abstract
A 26-year-old woman was admitted to hospital with high fever, severe tonsillitis, and gastroenteritis. Because of Graves' disease she had been treated with methimazole for 18 months. Leukopenia and agranulocytosis in combination with a typical bone marrow, exhibiting a complete arrest of myelopoiesis at the stage of promyelocytes led to the diagnosis of an antithyroid therapy induced agranulocytosis. After 1 week of antibiotic treatment without changes in neutrophil counts, granulocyte colony stimulating factor treatment at a dose of 300 μg/day subcutaneously was started. Twenty-four hours after the first administration the neutrophil counts began to rise, to 4389/μl, with a maximum after the third administration and stabilizing at normal levels within 10 days. Since agranulocytosis is considered to be a severe and fatal complication of methimazole therapy, treatment with granulocyte colony stimulating factor seems to be useful for this life-threatening condition.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- ANC:
-
absolute neutrophil count
- G-CSF:
-
granulocyte colony stimulating factor
- GM-CSF:
-
granulocyte macrophage colony stimulating factor
References
Björkholm M, Pisa P, Arver S, Beran M (1992) Haematologic effects of granulocyte-macrophage-colony-stimulating factor in a patient with thiamazole-induced agranulocytosis. J Intern Med 232:443–445
Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG (1993) Granulocyte colony-stimulating factor “mobilized” peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031–2035
Delannoy A (1992) GM-CSF therapy for drug induced agranulocytosis. J Intern Med 231:269–271
Heinrich B, Gross M, Goebel FD (1989) Methimazole-induced agranulocytosis and granulocyte-colony-stimulating factor. Ann Intern Med 111:621–622
International Agranulocytosis and Aplastic Anaemia Study (1988) Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. Br Med J 297:262–265
Muroi K, Ito M, Sasaki R, Suda T, Sakamoto S, Miura Y (1989) Treatment of drug-induced agranulocytosis with granulocyte-colony-stimulating-factor. Lancet II:55
Patton WN, Holyoake TL, Yates JM, Boughton BJ, Franklin IM (1992) Accelerated recovery from drug-induced agranulocytosis following G-CSF therapy. Br J Haematol 80:564–565
Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM (1992) Effect of peripheral-blood progenitor cells mobilised by filgastrim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1:640–644
Weide R, Köppler H, Heymanns J, Pfügler K-H, Havemann K (1992) Successful treatment of clozapine induced agranulocytosis with granulocyte-colony-stimulating factor (G-CSF). Br J Haematol 80:557–559
Willfort A, Lorber C, Kapiotis S, Sertl S, Hainz R, Kirchweger P, Jäger U, Kyrle PA, Lechner K, Geissler K (1993) Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rhG-CSF). Ann Hematol 66:241–244
Yokoyama K, Sato T, Nakajima S, Chino M, Komatsumoto S, Nara M (1992) Successful treatment of methimazole-induced agranulocytosis by granulocyte-colony-stimulating-factor. Am J Hematology 40:76–77
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adorf, D., Grajer, K.H., Kaboth, W. et al. Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor. Clin Investig 72, 390–392 (1994). https://doi.org/10.1007/BF00252834
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00252834